Article

A walk down memory lane - My steps through colorectal cancer advocacy

Author(s):

Most of my life I wasn't even aware that colorectal cancer existed. At 31, that innocence vanished and with it began my journey into the world of stage 4 colon cancer. Only one chemotherapy existed then and it wasn't expected to do much good. I was fortunate to find the ACOR (ACOR.org) listserv and another survivor, Shelly Weiler, who encouraged me to begin treatment. I did. I have since benefited from the research that was rampant for colon cancer. New drugs were developed and I received them first as single agents (one at a time) and then in the varying combinations that are used today. My tumors were responsive and slow growing at first.Research stagnated and my luck changed as the tumors in my liver began to grow uncontrollably. It seemed that nothing could stop them and we were fortunate to find out about radioembolization, or SIR-Spheres, which shrunk my tumors and allowed me to begin systemic therapy once again. Friends knew of my journey and I began to hear about the power of advocacy. Timid and quiet, it was foreign to me. But as I watched others making creating change I felt like I should, too.In 2006, I joined One Voice Against Cancer to take colorectal cancer awareness to Capitol Hill for the first time and at the same time discovered Fight Colorectal Cancer (fightcolorectalcancer.org). I was terrified that trip and spent much of the training in tears. There were other wonderful Texans that took me under their wing, though, and helped me to share my story. I had the opportunity to meet my representative during that trip, Jeb Hensarling, and to share that I was able to stand on the Capitol steps and walk into his office because of research. I told him I wanted to watch my daughters grow up and that without more research, I wouldn't be able to do that. When I left, I knew my words had made an impact.Our stories make a difference. No one should experience the helplessness and hopelessness of colorectal cancer. It is preventable, treatable and beatable. Taking action is easy: fightcolorectalcancer.org/policy/take_action_this_march. My story makes a difference. Your story can make a difference, too. So I challenge you - be the difference!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content